Literature DB >> 8707109

Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin.

A W Harris1, P A Gummett, J J Misiewicz, J H Baron.   

Abstract

BACKGROUND: Patients with duodenal ulcer (DU) have high basal (BAO) and peak (PAO) acid outputs. The effect of Helicobacter pylori eradication on these variables is unclear. AIM: To discover if gastric acid hypersecretion in patients with DU is caused by H pylori. PATIENTS AND METHODS: BAO, gastrin releasing peptide (GRP), and pentagastrin stimulated PAO in 10 H pylori negative controls, and in 10 H pylori positive patients with DU was measured before and six months after H pylori eradication. H pylori status was determined by histology, culture, and by the 13C-urea breath test. After collecting a 30 minute basal aspirate, GRP 40 pmol/kg/h was infused for 45 minutes, and after a 30 minute washout, pentagastrin 6 micrograms/kg was injected intramuscularly.
RESULTS: Basal and stimulated acid output (PAOGRP and PAOPg) were significantly higher in H pylori positive DU than in H pylori negative controls. Six months after H pylori eradication, basal and stimulated acid outputs were all significantly lower than before H pylori eradication.
CONCLUSIONS: This study has shown that BAO, PAOGRP, and PAOPg are higher in H pylori positive DU than in H pylori negative controls. All decreased significantly six months after H pylori eradication, to fall within the range of controls. These results are compatible with a hypothesis that acid hypersecretion in duodenal ulcer disease is caused by H pylori infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707109      PMCID: PMC1383145          DOI: 10.1136/gut.38.5.663

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  The relationship between the acid output of the stomach following "maximal" histamine stimulation and the parietal cell mass.

Authors:  W I CARD; I N MARKS
Journal:  Clin Sci       Date:  1960-02       Impact factor: 6.124

2.  Theorigin and survival of gastric parietal cells in the mouse.

Authors:  H Ragins; F Wincze; S M Liu; M Dittbrenner
Journal:  Anat Rec       Date:  1968-09

3.  Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats.

Authors:  G P Crean; M W Marshall; R D Rumsey
Journal:  Gastroenterology       Date:  1969-08       Impact factor: 22.682

4.  Effects of bombesin on gastrin and gastric acid secretion in patients with duodenal ulcer.

Authors:  G Delle Fave; A Kohn; L De Magistris; B Annibale; R Bruzzone; C Sparvoli; C Severi; A Torsoli
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

5.  Bombesin: action on gut hormones and calcium in man.

Authors:  M A Ghatei; R T Jung; J C Stevenson; C J Hillyard; T E Adrian; Y C Lee; N D Christofides; D L Sarson; K Mashiter; I MacIntyre; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

6.  Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.

Authors:  E el-Omar; I Penman; C A Dorrian; J E Ardill; K E McColl
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

7.  Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of helicobacter pylori in duodenal ulcer patients. A controlled study.

Authors:  F Parente; G Maconi; O Sangaletti; M Minguzzi; L Vago; G Bianchi Porro
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

8.  Divergent effects of bombesin and bethanechol on stimulated gastric secretion in duodenal ulcer and in normal men.

Authors:  C A Helman; B I Hirschowitz
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

9.  The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man.

Authors:  S M Wood; R T Jung; J D Webster; M A Ghatei; T E Adrian; N Yanaihara; C Yanaihara; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1983-10       Impact factor: 6.124

10.  Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up.

Authors:  G M Forbes; M E Glaser; D J Cullen; J R Warren; K J Christiansen; B J Marshall; B J Collins
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

View more
  24 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Helicobacter pylori infection and gastrointestinal hormones:a review.

Authors:  Xiang-Qian Huang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Mechanisms involved in Helicobacter pylori induced duodenal ulcer disease:an overview.

Authors:  Lars Olbe; Lars Fandriks; Annika Hamlet; Ann-Mari Svennerholm; Ann-Catrin Thoreson
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

5.  Effect of interleukin-8 on histamine release from totally isolated vascularly perfused rat stomach.

Authors:  Koji Yakabi; Shoki Ro; Seiichi Miura; Teruyuki Tanaka; Shino Ohno; Junichi Kawashima; Susumu Kurosawa; Takashi Nakamura
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

6.  [1997 gastroenterology update--I].

Authors:  W Fischbach; S S Gro; J Schölmerich; C Ell; P Layer; W E Fleig; H Zirngibl
Journal:  Med Klin (Munich)       Date:  1998-02-15

7.  Helicobacter pylori, gastric acid, and duodenal gastric metaplasia.

Authors:  K E McColl
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

8.  Helicobacter pylori and duodenal ulcers.

Authors:  O Oshowo; M Hobsley
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

9.  The diurnal profile of gastric pepsin activity is reduced with Helicobacter pylori infection.

Authors:  J L Newton; O F W James; G V Williams; A Allen
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

10.  Interleukin-8 enhances tetragastrin-stimulated acid secretion in vivo.

Authors:  K Yakabi; H Mimura; H Iwabuchi; S Ro; T Nakamura
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.